Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures.

Methods: Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay.

Results: We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children.

Discussion: Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083310PMC
http://dx.doi.org/10.3389/fped.2023.1020865DOI Listing

Publication Analysis

Top Keywords

omicron ba1
12
seropositive children
8
adults children
8
infection ancestral
8
wuhan strain
8
strain sars-cov-2
8
participants detectable
8
813% 13/16
8
cd8 cells
8
ba1
7

Similar Publications

Article Synopsis
  • - SARS-CoV-2 is still a major cause of death in North America, and this study examines how methotrexate and tumor necrosis factor inhibitors (TNFi) affect vaccine responses in patients with immune-mediated inflammatory diseases (IMID).
  • - Researchers collected and analyzed serum samples from 479 adults with conditions like inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) across Canada to evaluate neutralization responses to COVID-19 vaccination.
  • - The results indicated that both methotrexate and TNFi independently reduced the ability to neutralize the virus, underscoring the need for careful vaccination strategies as COVID-19 remains widespread.
View Article and Find Full Text PDF

Evaluation of Vaccine Strategies among Healthcare Workers during COVID-19 Omicron Outbreak in Taiwan.

Vaccines (Basel)

September 2024

Division of Pediatric Infectious Diseases, Departments of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.

Article Synopsis
  • This study evaluated the safety and immune response of various COVID-19 vaccines among healthcare workers in Taiwan during the Omicron variant outbreak, comparing their effectiveness.
  • Conducted from March 2021 to July 2023, the research involved 710 healthcare workers who received different vaccines, with blood samples taken to measure antibody levels and record side effects.
  • Results showed that mRNA vaccines like Moderna offered the highest initial antibody levels and effectiveness, while regular booster doses significantly boosted immunity and reduced COVID-19 cases among workers.
View Article and Find Full Text PDF
Article Synopsis
  • - COVID-19 continues to pose risks to health, including long COVID, necessitating ongoing evaluation of vaccines and immunity against different variants of the virus.
  • - A study analyzed immunity levels from vaccines, past infections, and hybrid immunity from December 2021 to August 2023 in Czechia, finding that recent booster vaccination significantly protects against severe COVID-19, while older vaccinations achieve less protection.
  • - The study concludes that while vaccination is still effective in preventing severe COVID-19, its effects diminish over time, emphasizing the need for booster shots, and that prior immunity offers limited protection against long COVID after infection.
View Article and Find Full Text PDF

Clusters of nosocomial coronavirus disease 2019 (COVID-19) have been reported globally during the recent pandemic. Unfortunately, these clusters negatively affect inpatient morbidity, mortality, and hospital functioning. Using epidemiological data and whole-genome sequencing (WGS) of SARS-CoV-2, this study investigated the outbreak of COVID-19 at a university hospital.

View Article and Find Full Text PDF

Pairwise compatibility between virus and host proteins can dictate the outcome of infection. During transmission, both inter- and intraspecies variabilities in receptor protein sequences can impact cell susceptibility. Many viruses possess mutable viral entry proteins and the patterns of host compatibility can shift as the viral protein sequence changes.

View Article and Find Full Text PDF